ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v16i3.2024ppharm-1734Research ArticleКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИCLINICAL RECOMMENDATIONSСуправентрикулярные (наджелудочковые) тахикардии у детейSupraventricular Tachycardia in Childrenhttps://orcid.org/0000-0001-8195-5682КовалёвИ. А.KovalevIgor A.

Ковалёв Игорь Александрович - доктор медицинских наук, профессор, заведующий отделом детской кардиологии и аритмологии.

125412, Москва, ул. Талдомская, д. 2, тел.: +7 (495) 483-84-09

Moscow

igor.kovalev64@mail.ruhttps://orcid.org/0000-0002-9247-4523ХамнагадаевИ. А.KhamnagadaevIgor A.

Москва

Moscow

https://orcid.org/0000-0002-2056-4060СвинцоваЛ. И.SvintsovaLilia I.https://orcid.org/0000-0002-6865-0136КручинаТ. К.KruchinaTatiana K.https://orcid.org/0000-0002-6662-3548СадыковаД. И.SadykovaDinara I.https://orcid.org/0000-0003-0501-405XСабироваД. Р.SabirovaDina R.https://orcid.org/0000-0003-2701-1079ХабибрахмановаЗ. Р.KhabibrakhmanovaZulfiya R.https://orcid.org/0000-0001-7115-0186ШкольниковаМ. А.ShkolnikovaMaria A.

Москва

Moscow

Научно-исследовательский клинический институт педиатрии им. академика Ю.Е. Вельтищева, Российский национальный исследовательский медицинский университет им. Н.И. ПироговаРоссияVeltischev Research and Clinical Institute for Pediatrics, Pirogov Russian National Research Medical UniversityRussian FederationНаучно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр, Российская академия наукРоссияCardiology Research Institute Tomsk National Research Medical Center, Russian Academy of SciencesRussian FederationСанкт-Петербургский государственный педиатрический медицинский университетРоссияSt. Petersburg State Pediatric Medical UniversityRussian FederationКазанский государственный медицинский университетРоссияKazan State Medical UniversityRussian Federation201906092019163133143Copyright © Ковалёв И.А., Хамнагадаев И.А., Свинцова Л.И., Кручина Т.К., Садыкова Д.И., Сабирова Д.Р., Хабибрахманова З.Р., Школьникова М.А., 20192019Ковалёв И.А., Хамнагадаев И.А., Свинцова Л.И., Кручина Т.К., Садыкова Д.И., Сабирова Д.Р., Хабибрахманова З.Р., Школьникова М.А.Kovalev I.A., Khamnagadaev I.A., Svintsova L.I., Kruchina T.K., Sadykova D.I., Sabirova D.R., Khabibrakhmanova Z.R., Shkolnikova M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/1734

Нарушения ритма и проводимости сердца занимают одно из ведущих мест в структуре сердечно-сосудистой патологии у детей. Суправентрикулярные тахикардии — тахиаритмии, обусловленные аномальным возбуждением миокарда с локализацией источника ритма выше бифуркации пучка Гиса — в предсердиях, атриовентрикулярном соединении (узле), а также аритмии с циркуляцией волны возбуждения между предсердиями и желудочками с участием дополнительных предсердно-желудочковых соединений. Коллектив авторов представляет разработанные на основании принципов доказательной медицины клинические рекомендации, включающие все этапы диагностики и лечения детей с суправентрикулярными тахикардиями. Использование рекомендаций в клинической практике позволит осуществлять выбор наилучшей стратегии в диагностике и лечении суправентрикулярной тахикардии у конкретного пациента.

Rhythm and conduction disorders of the heart occupy one of the leading places in the structure of cardiovascular pathology in children. Supraventricular tachycardias means tachyarrhythmias, caused by abnormal myocardial excitation with the source of rhythm localization above the His bundle bifurcation — in the atria, atrioventricular junction (node), and also arrhythmias with circulation of the excitation wave between the atria and the ventricles with additional atrial compounds. The team of authors presents clinical recommendations developed on the principles of evidence-based medicine, including all stages of diagnosis and treatment of children with supraventricular tachycardias. The use of recommendations in clinical practice allows to selecte the best strategy for diagnosis and treatment of supraventricular tachycardia in a particular patient.

нарушения ритма сердцасуправентрикулярная тахикардияантиаритмическая терапиядетиcardiac arrhythmiassupraventricular tachycardiaantiarrhythmic therapychildrenОтсутствуетNot specifiedReferencesKo JK, Deal BJ, Strasburger JF, Benson DW Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69(12):1028-1032. doi: 10.1016/0002-9149(92)90858-v.Ko JK, Deal BJ, Strasburger JF, Benson DW Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69(12):1028-1032. doi: 10.1016/0002-9149(92)90858-v.Moak JP Supraventricular tachycardia in the neonate and infant. Prog Pediatr Cardiol. 2000;11(1):25-38. doi: 10.1016/s1058-9813(00)00033-3.Moak JP Supraventricular tachycardia in the neonate and infant. Prog Pediatr Cardiol. 2000;11(1):25-38. doi: 10.1016/s1058-9813(00)00033-3.Practical management of pediatric cardiac arrhythmias. Ed by VL Zeigler, PC Gillette. New York, Futura Publishing Company, Inc.; 2001. 422 p.Practical management of pediatric cardiac arrhythmias. Ed by VL Zeigler, PC Gillette. New York, Futura Publishing Company, Inc.; 2001. 422 p.Seslar SP, Garrison MM, Larison C, Salerno JC. A multi-institutional analysis of inpatient treatment for supraventricular tachycardia in newborn and infants. Pediatr Cardiol. 2013;34(2):408-414. doi: 10.1007/s00246-012-0474-6.Seslar SP, Garrison MM, Larison C, Salerno JC. A multi-institutional analysis of inpatient treatment for supraventricular tachycardia in newborn and infants. Pediatr Cardiol. 2013;34(2):408-414. doi: 10.1007/s00246-012-0474-6.Аритмии сердца: механизмы, диагностика, лечение. / Под ред. В.Дж. Мандела. Пер. с англ. Т.2. — М.: Медицина, 1996. — 206 с.Cardiac arrhythmias: their mechanisms, diagnosis, and management. Ed by WJ Mandel. Vol. 2. Transl. from English. Moscow: Meditsina; 1996. 206 p. (In Russ).Quattrocelli A, Lang J, Davis A, Pflaumer A. Age makes a difference: symptoms in pediatric supraventricular tachycardia. J Arrhythm. 2018;34(5):565-571. doi: 10.1002/joa3.12103.Quattrocelli A, Lang J, Davis A, Pflaumer A. Age makes a difference: symptoms in pediatric supraventricular tachycardia. J Arrhythm. 2018;34(5):565-571. doi: 10.1002/joa3.12103.Baksiene ND, Sileikiene R, Sileikis V, et al. Atrial tachyarrhythmias in infants. Turk J Pediatr. 2008;50(2):143-148.Baksiene ND, Sileikiene R, Sileikis V, et al. Atrial tachyarrhythmias in infants. Turk J Pediatr. 2008;50(2):143-148.Скударнова И.М., Соболева Н.В., Мычка Н.В. Гормоны щитовидной железы: пособие для врачей. — Кольцово: ЗАО «Вектор-Бест», 2006. — 32 с.Skudarnova IM, Soboleva NV, Mychka NV. Gormony shchitovidnoj zhelezy: posobie dlya vrachej. Kol'tsovo: ZAO «Vektor-Best»; 2006. 32 р. (In Russ).Tracy CM, Akhtar M, DiMarco JP et al. American College of Cardiology/American Heart Association clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion. A report of the American College of Cardiology/ American Heart Association / American College of Physicians — American Society of Internal Medicine Task Force on clinical competence. J Am Coll Cardiol. 2000;36(5):1725-1736. doi: 10.1016/s0735-1097(00)01085-8.Tracy CM, Akhtar M, DiMarco JP et al. American College of Cardiology/American Heart Association clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion. A report of the American College of Cardiology/ American Heart Association / American College of Physicians — American Society of Internal Medicine Task Force on clinical competence. J Am Coll Cardiol. 2000;36(5):1725-1736. doi: 10.1016/s0735-1097(00)01085-8.Akdeniz C, Ergul Y, Kiplapinar N, Tuzcu V. Catheter ablation of drug resistant supraventricular tachycardia in neonates and infants. Cardiol J. 2013;20(3):241-246. doi: 10.5603/CJ.2013.0068.Akdeniz C, Ergul Y, Kiplapinar N, Tuzcu V. Catheter ablation of drug resistant supraventricular tachycardia in neonates and infants. Cardiol J. 2013;20(3):241-246. doi: 10.5603/CJ.2013.0068.Brugada J, Blom N, Sarquella-Brugada G, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15(9):1337-1382. doi: 10.1093/europace/eut082.Brugada J, Blom N, Sarquella-Brugada G, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15(9):1337-1382. doi: 10.1093/europace/eut082.Rodriguez LM, de Chillou C, Schlapfer J, et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol. 1992;70(13):1213-1215. doi: 10.1016/0002-9149(92)90060-c.Rodriguez LM, de Chillou C, Schlapfer J, et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol. 1992;70(13):1213-1215. doi: 10.1016/0002-9149(92)90060-c.Рекомендации по проведению реанимационных мероприятий Европейского совета по реанимации (пересмотр 2015 г.). / Нац. совет по реанимации; под ред. В.В. Мороза; пер. с англ. А.А. Митрохина. 3-е изд., перераб. и доп. — М.: НИИОР НСР 2016. — 191 с.Rekomendatsii po provedeniyu reanimatsionnykh meropriyatij Evropejskogo soveta po reanimatsii (peresmotr 2015 g.). Nats. sovet po reanimatsii; ed by VV Moroz; translated from English AA Mitrokhin. 3rd ed. revised and updated. Moscow: NIIOR NSR; 2016. 191 p. (In Russ).Giglia TM, Massicotte MR Tweddell JS, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013;128(24):2622-2703. doi: 10.1161/01.cir.0000436140.77832.7a.Giglia TM, Massicotte MR Tweddell JS, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013;128(24):2622-2703. doi: 10.1161/01.cir.0000436140.77832.7a.Кручина Т.К., Васичкина Е.С., Новик Г.А., Егоров Д.Ф. Синдром Вольфа-Паркинсона-Уайта у детей: клиника, диагностика, лечение // Педиатрическая фармакология. — 2011. — Т.8. — №5. — С. 49-53.Kruchina TK, Vasichkina YS, Novik GA, Egorov DF. Wolff-Parkinson-White syndrome in children: clinical course, diagnostics, treatment. Pediatricheskaya farmakologiya. 2011;8(5):49-53. (In Russ).Blaufox AD. Cateter ablation of tachyarrhythmias in small children. Indian Pacing Electrophysiol J. 2005;5(1):51-62.Blaufox AD. Cateter ablation of tachyarrhythmias in small children. Indian Pacing Electrophysiol J. 2005;5(1):51-62.Saul RJ, Kanter RJ; Writing Committee, et al. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: Developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC). Heart Rhythm. 2016;13(6):e251-289. doi: 10.1016/j.hrthm.2016.02.009.Saul RJ, Kanter RJ; Writing Committee, et al. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: Developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC). Heart Rhythm. 2016;13(6):e251-289. doi: 10.1016/j.hrthm.2016.02.009.Svintsova LI, Popov SV, Kovalev IA. Radiofrequency ablation of drug-refractory arrhythmias in small children younger than 1 year of age: single-center experience. Pediatr Cardiol. 2013;34(6):1321-1329. doi: 10.1007/s00246-013-0643-2.Svintsova LI, Popov SV, Kovalev IA. Radiofrequency ablation of drug-refractory arrhythmias in small children younger than 1 year of age: single-center experience. Pediatr Cardiol. 2013;34(6):1321-1329. doi: 10.1007/s00246-013-0643-2.Pelliccia A, Fagard R, Bj0rnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422-1445. doi: 10.1093/eurheartj/ehi325.Pelliccia A, Fagard R, Bj0rnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422-1445. doi: 10.1093/eurheartj/ehi325.Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2343-2349. doi: 10.1016/j.jacc.2015.09.032.Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2343-2349. doi: 10.1016/j.jacc.2015.09.032.Ko J. Left ventricular dysfunction and dilated cardiomyopathy in infants and children with wolff-Parkinson-white syndrome in the absence of tachyarrhythmias. Korean Circ J. 2012;42(12):803-808. doi: 10.4070/kcj.2012.42.12.803.Ko J. Left ventricular dysfunction and dilated cardiomyopathy in infants and children with wolff-Parkinson-white syndrome in the absence of tachyarrhythmias. Korean Circ J. 2012;42(12):803-808. doi: 10.4070/kcj.2012.42.12.803.Fazio G, Mongiovi' M, Sutera L, et al. Segmental dyskinesia in Wolff-Parkinson-White syndrome: a possible cause of dilatative cardiomyopathy. Int J Cardiol. 2008;123(2):e31-34. doi: 10.1016/j.ijcard.2006.11.109.Fazio G, Mongiovi' M, Sutera L, et al. Segmental dyskinesia in Wolff-Parkinson-White syndrome: a possible cause of dilatative cardiomyopathy. Int J Cardiol. 2008;123(2):e31-34. doi: 10.1016/j.ijcard.2006.11.109.Марцинкевич Г.И., Соколов А.А., Ковалев И.А., и др. Электромеханическое сопряжение миокарда в норме и у детей с синдромом WPW // Вестник аритмологии. — 2004. — №35. — С. 38-44.Martsinkevich GI, Sokolov AA, Kovalev IA, et al. Elektromekhanicheskoe sopryazhenie miokarda v norme i u detei s sindromom WPW. Journal of arrhythmology. 2004;(35):38-44. (In Russ).Хамнагадаев И.А., Школьникова М.А., Коков Л.С., и др. Диастолическая функция правого желудочка у больных с манифестным синдромом и электрокардиографическим феноменом Вольфа-Паркинсона-Уайта // Вестник аритмологии. — 2012. — №68. — С. 21-27.Khamnagadaev IA, Shkolnikova MA, Kokov LS, et al. Diastolic function of the right ventricle in patients with both manifesting syndrome and electrocardiographic phenomenon of Wolff-Parkinson-White. Journal of arrhythmology. 2012;(68):21-27. (In Russ).

The authors declare that there are no conflicts of interest present.